Loading...

Pacific Blue™ anti-human CD66b Antibody

Pricing & Availability
Clone
G10F5 (See other available formats)
Regulatory Status
RUO
Workshop
VI MA81
Other Names
CD67, CGM6, NCA-95, CEACAM8
Isotype
Mouse IgM, κ
Ave. Rating
Submit a Review
Product Citations
publications
G10F5_PB_CD66b_Antibody_FC_032014
Human peripheral blood granulocytes were stained with CD66b (clone G10F5) Pacific Blue™ (filled histogram) or mouse IgM, κ Pacific Blue™ isotype control (open histogram).
  • G10F5_PB_CD66b_Antibody_FC_032014
    Human peripheral blood granulocytes were stained with CD66b (clone G10F5) Pacific Blue™ (filled histogram) or mouse IgM, κ Pacific Blue™ isotype control (open histogram).
See Pacific Blue™ spectral data
Cat # Size Price Quantity Check Availability Save
305111 25 tests 109€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
305112 100 tests 268€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD66b is a 95-100 kD glycosylphosphatidylinositol (GPI)-linked protein also known as CD67, CGM6, and NCA-95. CD66b is a member of the immunoglobulin superfamily, carcinoembryonic antigen (CEA)-like subfamily. CD66b, expressed on granulocytes, has been reported to induce activation in neutrophils and to be involved in heterophilic adhesion with CD66c.

Product Details
Technical data sheet

Product Details

Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography and conjugated with Pacific Blue™ under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

* Pacific Blue™ has a maximum emission of 455 nm when it is excited at 405 nm. Prior to using Pacific Blue™ conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Violet Laser (405 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen, formalin-fixed paraffin-embedded tissue sections, and spatial biology (IBEX)5,6.

Application References

(PubMed link indicates BioLegend citation)
  1. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
  2. Kishimoto T, et al. Eds. 1997. Leucocyte Typing VI. Garland Publishing Inc. London.
  3. Norling LV, et al. 2012. Arterioscler Thromb Vasc Biol. 32:1970. PubMed
  4. Meinke P, et al. 2015. Neuroimmunol Discord. 25:127. PubMed
  5. Radtke AJ, et al. 2020. Proc Natl Acad Sci USA. 117:33455-33465. (SB) PubMed
  6. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Gunn BM et al. 2018. Cell host & microbe. 24(2):221-233 . PubMed
  2. King LB et al. 2018. Cell host & microbe. 23(1):101-109 . PubMed
  3. Spolski R et al. 2019. Elife. 8 pii: e45501. PubMed
  4. Bornholdt ZA et al. 2019. Cell host & microbe. 25(1):49-58 . PubMed
  5. Alcántara‐Hernández M et al. 2017. Immunity. 47(6):1037-1050 . PubMed
  6. Lu LL et al. 2016. Cell. 167(2):433-443 . PubMed
  7. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  8. Gilchuk P, et al. 2020. Immunity. 52:388. PubMed
  9. Boudreau CM, et al. 2020. J Clin Invest. 130:662. PubMed
  10. Jennewein MF, et al. 2020. Cell. 178(1):202-215.e14.. PubMed
  11. Ilinykh PA, et al. 2018. PLoS Pathog. 14:e1007204. PubMed
  12. Om K, et al. 2020. PLoS Pathog. 16:e1008764. PubMed
  13. Kwok I, et al. 2020. Immunity. 53(2):303-318.e5. PubMed
  14. Alter G, et al. 2020. Cell. 183(1):185-196.e14. PubMed
  15. Gunn BM, et al. 2021. Immunity. 54(4):815-828.e5. PubMed
  16. Rossignol ED, et al. 2021. Cell Reports. 35(8):109167. PubMed
  17. Williamson LE, et al. 2021. Cell. 184:4430. PubMed
  18. Hubbard JJ, et al. 2020. J Exp Med. :217. PubMed
  19. Offersen R, et al. 2020. Cell Rep. 33:108502. PubMed
  20. Barrett JR, et al. 2021. Nat Med. 27:279. PubMed
  21. Atyeo C, et al. 2021. JCI Insight. 6:. PubMed
  22. Atyeo C, et al. 2021. Cell. 184:628. PubMed
  23. Bartsch YC, et al. 2021. Nat Commun. 12:1018. PubMed
  24. Cadena AM, et al. 2021. Nat Commun. 12:1474. PubMed
  25. Jundi B, et al. 2021. JCI Insight. 6:e148866. PubMed
  26. Minassian AM, et al. 2021. Med (N Y). 2:701. PubMed
  27. Grace PS, et al. 2021. Front Immunol. 12:679973. PubMed
  28. Gorman MJ, et al. 2021. Cell Rep Med. 2:100405. PubMed
  29. Krampert L, et al. 2021. Front Immunol. 12:712948. PubMed
  30. Pullen KM, et al. 2021. Cell Rep. 37:109959. PubMed
  31. Herman JD, et al. 2021. Nat Commun. 12:6853. PubMed
  32. Das J, et al. 2021. Med (N Y). 2:1269. PubMed
  33. House RV, et al. 2022. PLoS One. 17:e0267796. PubMed
  34. Chen RE, et al. 2021. Med (N Y). 2:1327. PubMed
  35. Kaplonek P, et al. 2022. Immunity. 55:355. PubMed
  36. Boudreau CM, et al. 2022. Cell Rep. 38:110337. PubMed
  37. Atyeo C, et al. 2022. Nat Commun. 13:3571. PubMed
  38. Malherbe DC, et al. 2022. NPJ Vaccines. 7:83. PubMed
  39. Dolatshahi S, et al. 2022. Sci Rep. 12:14937. PubMed
  40. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  41. Zelter T, et al. 2022. EMBO Rep. 23:e53641. PubMed
  42. LaSalle TJ, et al. 2022. Cell Rep Med. 3:100779. PubMed
  43. Kaplonek P, et al. 2022. Sci Transl Med. 14:eabm2311. PubMed
  44. Davies LRL, et al. 2022. Sci Transl Med. 14:eabm4065. PubMed
  45. Bernshtein B, et al. 2022. Cell Rep. 40:111216. PubMed
  46. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  47. Rohwedder I, et al. 2023. JCI Insight. 8: . PubMed
  48. Spatola M, et al. 2022. J Infect Dis. 226:738. PubMed
  49. Bartsch YC, et al. 2022. Sci Transl Med. 14:eabn9237. PubMed
  50. Herman JD, et al. 2022. Cell Rep Med. 3:100811. PubMed
  51. Loos C, et al. 2023. NPJ Vaccines. 8:34. PubMed
  52. Boudreau CM, et al. 2023. Cell Rep Med. 4:100975. PubMed
  53. Roy V, et al. 2023. NPJ Vaccines. 8:39. PubMed
  54. Adams LE, et al. 2023. Cell Rep. 42:112326. PubMed
  55. Bartsch YC, et al. 2023. iScience. 26:106582. PubMed
  56. Kaplonek P, et al. 2023. Nat Immunol. . PubMed
RRID
AB_2563293 (BioLegend Cat. No. 305111)
AB_2563294 (BioLegend Cat. No. 305112)

Antigen Details

Structure
Ig superfamily, CEA antigen group, GPI-linked glycoprotein, 95-100 kD
Distribution

Granulocytes

Function
Cell adhesion, neutrophil activation
Ligand/Receptor
CD66c
Cell Type
Granulocytes, Neutrophils
Biology Area
Immunology
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Kuijpers T, et al. 1993. J. Immunol. 151:4934.
2. Kuroki M, et al. 1992. J. Leuk. Biol. 52:551.

Gene ID
1088 View all products for this Gene ID
UniProt
View information about CD66b on UniProt.org
Go To Top Version: 3    Revision Date: 01.05.2017

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account